References
Beck CA, Metz LM, Svenson LW, Patten SB (2005) Regional variation of multiple sclerosis prevalence in Canada. Mult Scler 11:516–519
Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7:268–277
Hernan MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H (2005) Cigarette smoking and the progression of multiple sclerosis. Brain 128:1461–1465
Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A (2005) Temporal relationship between elevation of epstein–barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293:2496–2500
Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296:2832–2838
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952
Pugliatti M, Sotgiu S, Rosati G (2002) The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 104:182–191
Saadatnia M, Etemadifar M, Maghzi AH (2007) Multiple sclerosis in Isfahan, Iran. Int Rev Neurobiol 79:357–375
Sadovnick AD, Risch NJ, Ebers GC (1998) Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 25:216–221
Smestad C, Sandvik L, Holmoy T, Harbo HF, Celius EG (2008) Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway. J Neurol 255:49–55
Acknowledgments
This study was funded by the Multiple Sclerosis Society of Canada Scientific Research Foundation. The authors would like to thank all patients who generously participated in this study and physicians participating in the CCPGSMS: Vancouver, BC (A. Traboulsee, V. Devonshire, S. A. Hashimoto, J. Hooge, L. Kastrukoff, J. J. F. Oger); Calgary, AB (L. Metz); Edmonton, AB (S. Warren); Saskatoon, SK (W. Hader, K. Knox); Winnipeg (R. A. Marrie), London, ON (M. Kremenchutzky, G. Rice); Ottawa, ON (M. Freedman); Kingston, ON (D. Brunet); Toronto, ON (P. O’Connor, T. Gray, M. Hohol); Montreal, QC (P. Duquette, Y. Lapierre); Halifax, NS (T. J. Murray, V. Bhan, C. Maxner); and St John’s, NL (M. Stefanelli).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guimond, C., Dyment, D.A., Ramagopalan, S.V. et al. Prevalence of MS in Iranian Immigrants to British Columbia, Canada. J Neurol 257, 667–668 (2010). https://doi.org/10.1007/s00415-009-5417-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5417-7